Therefore, this study investigated the potential pretreatment prognostic value of serum neuronal and nonneuronal biomarkers, namely NSE, S100β, GFAP, NGAL, LDH, and lactate, in patients undergoing supratentorial primary brain tumor resection. The gene discussed is GFAP; the disease is brain neoplasm.